ly3009120 and osimertinib

ly3009120 has been researched along with osimertinib* in 1 studies

*osimertinib: an EGFR tyrosine kinase inhibitor [MeSH]

*osimertinib: an EGFR tyrosine kinase inhibitor [MeSH]

Other Studies

1 other study(ies) available for ly3009120 and osimertinib

ArticleYear
The combination of osimertinib with Raf inhibitor overcomes osimertinib resistance induced by KRAS amplification in EGFR-mutated lung cancer cells.
    Experimental cell research, 2023, 09-01, Volume: 430, Issue:1

    Topics: Aniline Compounds; Animals; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Lung Neoplasms; Mice; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras)

2023
chemdatabank.com